CORCEPT THERAPEUTICS INC (CORT) Return on equity 2016–2025
CORCEPT THERAPEUTICS INC (CORT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
15.4%FY2025 · since FY2016: 19.7% → 15.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 15.4% | -5.4 pp |
| FY2024 | 20.8% | -0.2 pp |
| FY2023 | 20.9% | +0.7 pp |
| FY2022 | 20.2% | -9.7 pp |
| FY2021 | 29.9% | +9.7 pp |
| FY2020 | 20.3% | -5.1 pp |
| FY2019 | 25.4% | -2.0 pp |
| FY2018 | 27.3% | -40.3 pp |
| FY2017 | 67.6% | +47.9 pp |
| FY2016 | 19.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice